Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes

• Published in: Journal of dermatology 2024-09, Vol.51 (9), p.1187-1198
• Main Authors: Kitano, Takamichi, Koiwai, Toshikazu, Fujikawa, Koki, Mori, Sachi, Matsumoto, Tatsumi, Sato, Takashi
• Format: Article
• Language: English
• Subjects: Acne; acne vulgaris; Acne Vulgaris - drug therapy; Acne Vulgaris - pathology; AKT protein; Aminopyridines - pharmacology; Animals; Anti-Bacterial Agents - pharmacology; Antibacterial activity; anti‐bacterial agents; Auricle; Cell Differentiation - drug effects; Cells, Cultured; Clindamycin; Comedones; Cricetinae; Desaturase; Diacylglycerol O-Acyltransferase - antagonists & inhibitors; Diacylglycerol O-Acyltransferase - metabolism; Diglycerides; Dihydrotestosterone; Insulin; Insulin - metabolism; Lipid Droplets - drug effects; Lipid Droplets - metabolism; Mechanistic Target of Rapamycin Complex 1 - antagonists & inhibitors; Mechanistic Target of Rapamycin Complex 1 - metabolism; Mesocricetus; mRNA; Nadifloxacin; Original; Perilipin-1 - metabolism; Phosphorylation; Quinolones; Quinolones - pharmacology; Rapamycin; Ribosomal protein S6; Sebaceous gland; sebaceous glands; Sebaceous Glands - cytology; Sebaceous Glands - drug effects; Sebaceous Glands - metabolism; Sebaceous Glands - pathology; sebum; Sebum - drug effects; Sebum - metabolism; Stearoyl-CoA Desaturase - antagonists & inhibitors; Stearoyl-CoA Desaturase - metabolism; Topical application; TOR protein; TOR serine–threonine kinases; Transcription; Triglycerides - metabolism
• ISSN: 0385-2407; 1346-8138; 1346-8138
• DOI: 10.1111/1346-8138.17409

Acne vulgaris is a complex condition involving factors that affect the pilosebaceous unit. A primary manifestation of acne pathology is the development of comedones, often linked to the overproduction of sebum resulting from 5α‐dihydrotestosterone (5α‐DHT) and insulin activity. Ozenoxacin is a topical quinolone that exhibits potent antibacterial activity against Cutibacterium acnes (C. acnes). It is commonly used to treat acne associated with this bacterium; however, its effect on sebum production within the sebaceous glands remains unclear. In this study, the effects of ozenoxacin on sebum production were examined using insulin‐ and 5α‐DHT‐differentiated hamster sebocytes. Ozenoxacin showed a dose‐dependent inhibition of lipid droplet formation and triacylglycerol (TG) production, which is a major component of sebum. In addition, it suppressed the expression of diacylglycerol acyltransferase 1, stearoyl‐CoA desaturase‐1, and perilipin‐1 mRNA, all important factors involved in sebum synthesis, in a dose‐dependent manner. Moreover, ozenoxacin decreased phosphorylated 40S ribosomal protein S6 levels downstream of the mechanistic/mammalian target of rapamycin complex 1 (mTORC1), without altering the phosphorylation of Akt, an upstream regulator of mTORC1, in both insulin‐ and 5α‐DHT‐treated hamster sebocytes. Interestingly, nadifloxacin, but not clindamycin, exhibited a similar suppression of sebum production, albeit with lesser potency compared with ozenoxacin. Furthermore, a topical application of a 2% ozenoxacin‐containing lotion to the auricle skin of hamsters did not affect the size of the sebaceous glands or epidermal thickness. Notably, it decreased the amount of TG on the skin surface. The results provide novel insights into the sebum‐inhibitory properties of ozenoxacin, indicating its potential efficacy in controlling microbial growth and regulating sebum production for acne management.